The price of the drug against the coronavirus “Avifavir” in pharmacies will be about 8 thousand rubles, which is about 30% lower than the price of analogues.
This was announced by the head of the Russian Direct Investment Fund (RDIF) Kirill Dmitriev during a press conference.
At the exchange rate of the Moscow Exchange, 8,000 rubles is 103.7 US dollars.
“Our price will be about 8 thousand rubles,” he said, adding that the cost of the drug will be about 30% lower than its analogues.
“We believe that the price that a number of analogues have made – 12 thousand rubles, is a very high price. We deliberately delayed our entrance to pharmacies a little in order to provide a more reasonable price,” he added.
Dmitriev also noted that the price of Avifavir may decrease in the future. The fund will also work on its inclusion in the list of vital and essential medicines (vital and essential drugs). He stressed that the drug is available free of charge in Russian hospitals.
In May 2020, Avivavir received a registration certificate from the Russian Ministry of Health and became the world’s first favipiravir-based drug approved for the treatment of COVID-19. Since April of this year, 408 patients with confirmed coronavirus have taken part in the drug research in 35 medical centers throughout Russia. In October, the number of patients will increase to 460, the fund also noted.